Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy

The effect of radiotherapy during immunotherapy on immune-related adverse events (irAEs) is not fully understood. We herein report a 74-year-old woman diagnosed with lung adenocarcinoma with programmed death ligand 1 expression ≥50% and treated with pembrolizumab. She developed fatal immune thromboc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamanoi, Daisuke, Saruwatari, Koichi, Imamura, Kosuke, Sato, Ryo, Jodai, Takuya, Hamada, Shohei, Tomita, Yusuke, Saeki, Sho, Ueno, Shikiko, Yonemura, Yuji, Ichiyasu, Hidenori, Sakagami, Takuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259326/
https://www.ncbi.nlm.nih.gov/pubmed/34776479
http://dx.doi.org/10.2169/internalmedicine.7581-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259326/
https://www.ncbi.nlm.nih.gov/pubmed/34776479
http://dx.doi.org/10.2169/internalmedicine.7581-21

Ejemplares similares